Cell-Type Resolved Insights into the Cis-Regulatory Genome of NAFLD
The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing rapidly, and unmet treatment can result in the development of hepatitis, fibrosis, and liver failure. There are difficulties involved in diagnosing NAFLD early and for this reason there are challenges involved in its treatment...
Main Authors: | Trine V. Dam, Nicolaj I. Toft, Lars Grøntved |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/5/870 |
Similar Items
-
Exploring the Regulatory Role of ncRNA in NAFLD: A Particular Focus on PPARs
by: Anirban Goutam Mukherjee, et al.
Published: (2022-12-01) -
From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights
by: Alexandra Gatzios, et al.
Published: (2022-01-01) -
Insights into the Role of PPARβ/δ in NAFLD
by: Jiapeng Chen, et al.
Published: (2018-06-01) -
Mechanism and Progress of Natural Products in the Treatment of NAFLD-Related Fibrosis
by: Jin-Zhong Li, et al.
Published: (2023-12-01) -
Early induction of hepatic deiodinase type 1 inhibits hepatosteatosis during NAFLD progression
by: Eveline Bruinstroop, et al.
Published: (2021-11-01)